A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study Comparing the Analgesic Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain
Phase of Trial: Phase II
Latest Information Update: 25 Sep 2013
At a glance
- Drugs ABT 652 (Primary) ; Duloxetine
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 25 Sep 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 12 Jul 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.